ALLcrimesfood&drugstaxestelecomcommercehealthconservationtransportationagricultureveteransbrowse all titles »
0

21 U.S.C. § 364Definitions

submitted 88 years ago by Pub. L. 117-328 to r/title-21-FOOD-AND-DRUGS · 430 words · no verdicts yet

in plain englishAI-generated · not legal advice

This section defines five terms used in this part of the cosmetics law: adverse event, cosmetic product, facility, responsible person, and serious adverse event. It lists which businesses count as a covered "facility" and which do not. It also spells out what makes an adverse event "serious."

(1) Adverse event: An "adverse event" means any health-related event tied to using a cosmetic product, if that event is adverse. (2) Cosmetic product: A "cosmetic product" means a preparation of cosmetic ingredients that has a specific, set recipe, both what is in it and how much, made for use as a finished product. (3) Facility: (A) In general, a "facility" includes any place, including a place run by an importer, that manufactures or processes cosmetic products sold in the United States. (B) But "facility" does not include: (i) beauty shops and salons, unless they manufacture or process cosmetics on-site; (ii) cosmetic retailers, including individual sales representatives, direct sellers, retail distribution centers, and pharmacies, unless they manufacture or process cosmetics that are not sold directly to customers there; (iii) hospitals, doctors' offices, and health clinics; (iv) public health agencies and nonprofits that give cosmetics directly to consumers; (v) businesses like hotels and airlines that give out free cosmetics as part of another service; (vi) trade shows and similar places giving out free cosmetic samples; (vii) places that make cosmetics solely for research, evaluation, or production testing, not for retail sale; and (viii) places that only label, relabel, package, repackage, hold, or distribute cosmetics. (C) For that last exception, "packaging" and "repackaging" do not include simply filling a product container with a cosmetic. (4) Responsible person: The "responsible person" is the manufacturer, packer, or distributor whose name appears on the cosmetic's label, as required by section 364e(a) of this title or section 1453(a) of title 15. (5) Serious adverse event: An adverse event is "serious" if it either (A) results in death, a life-threatening experience, hospitalization as an inpatient, a lasting or major disability, a birth defect, an infection, or significant disfigurement, such as serious ongoing rashes, second- or third-degree burns, major hair loss, or a lasting change in appearance, beyond what is intended under normal, expected use, or (B) requires medical or surgical treatment, based on reasonable medical judgment, to prevent one of those outcomes from happening.
the actual law source: uscode.house.gov ↗public domain

In this subchapter:

(1) Adverse event

The term “adverse event” means any health-related event associated with the use of a cosmetic product that is adverse.

(2) Cosmetic product

The term “cosmetic product” means a preparation of cosmetic ingredients with a qualitatively and quantitatively set composition for use in a finished product.

(3) Facility
(A)In general.—

The term “facility” includes any establishment (including an establishment of an importer) that manufactures or processes cosmetic products distributed in the United States.

(B)

Such term does not include any of the following:

(i)

Beauty shops and salons, unless such establishment manufactures or processes cosmetic products at that location.

(ii)

Cosmetic product retailers, including individual sales representatives, direct sellers (as defined in section 3508(b)(2) of title 26), retail distribution facilities, and pharmacies, unless such establishment manufactures or processes cosmetic products that are not sold directly to consumers at that location.

(iii)

Hospitals, physicians’ offices, and health care clinics.

(iv)

Public health agencies and other nonprofit entities that provide cosmetic products directly to the consumer.

(v)

Entities (such as hotels and airlines) that provide complimentary cosmetic products to customers incidental to other services.

(vi)

Trade shows and other venues where cosmetic product samples are provided free of charge.

(vii)

An establishment that manufactures or processes cosmetic products that are solely for use in research or evaluation, including for production testing and not offered for retail sale.

(viii)

An establishment that solely performs one or more of the following with respect to cosmetic products:

(I)

Labeling.

(II)

Relabeling.

(III)

Packaging.

(IV)

Repackaging.

(V)

Holding.

(VI)

Distributing.

(C)Clarification.—

For the purposes of subparagraph (B)(viii), the terms “packaging” and “repackaging” do not include filling a product container with a cosmetic product.

(4) Responsible person

The term “responsible person” means the manufacturer, packer, or distributor of a cosmetic product whose name appears on the label of such cosmetic product in accordance with section 364e(a) of this title or section 1453(a) of title 15.

(5) Serious adverse event

The term “serious adverse event” means an adverse event that—

(A)

results in—

(i)

death;

(ii)

a life-threatening experience;

(iii)

inpatient hospitalization;

(iv)

a persistent or significant disability or incapacity;

(v)

a congenital anomaly or birth defect;

(vi)

an infection; or

(vii)

significant disfigurement (including serious and persistent rashes, second- or third-degree burns, significant hair loss, or persistent or significant alteration of appearance), other than as intended, under conditions of use that are customary or usual; or

(B)

requires, based on reasonable medical judgment, a medical or surgical intervention to prevent an outcome described in subparagraph (A).

Source credit: (June 25, 1938, ch. 675, § 604, as added Pub. L. 117–328, div. FF, title III, § 3502, Dec. 29, 2022, 136 Stat. 5847.)

history & why it existsrecord from the source credit
  • 1938Enacted · Pub. L. 117-328 · 136 Stat. 5847

A history note hasn’t been published yet. The record shows enactment by Pub. L. 117-328 on 1938-06-25.

all 0 arguments · sorted by: best

0/280

no arguments yet — make the first case